Sckell, Axel

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

Journal Article

Klenke, Frank Michael; Abdollahi, Amir; Bischof, Marc; Gebhard, Martha-Maria; Ewerbeck, Volker; Huber, Peter E; Sckell, Axel (2011). Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo. Strahlentherapie und Onkologie, 187(1), pp. 45-51. Heidelberg: Springer-Medizin-Verlag 10.1007/s00066-010-2116-3

Klenke, Frank M; Abdollahi, Amir; Bertl, Elisabeth; Gebhard, Martha-Maria; Ewerbeck, Volker; Huber, Peter E; Sckell, Axel (2007). Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo. BMC cancer, 7, p. 49. London: BioMed Central 10.1186/1471-2407-7-49

Klenke, Frank Michael; Gebhard, Martha-Maria; Ewerbeck, Volker; Abdollahi, Amir; Huber, Peter E; Sckell, Axel (2006). The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC cancer, 6, p. 9. London: BioMed Central 10.1186/1471-2407-6-9

This list was generated on Tue Dec 3 18:17:37 2024 CET.
Provide Feedback